356 related articles for article (PubMed ID: 24332702)
1. Systemic and local immune response in pigs intradermally and intramuscularly injected with inactivated Mycoplasma hyopneumoniae vaccines.
Martelli P; Saleri R; Cavalli V; De Angelis E; Ferrari L; Benetti M; Ferrarini G; Merialdi G; Borghetti P
Vet Microbiol; 2014 Jan; 168(2-4):357-64. PubMed ID: 24332702
[TBL] [Abstract][Full Text] [Related]
2. Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccine.
Marchioro SB; Maes D; Flahou B; Pasmans F; Del Pozo Sacristán R; Vranckx K; Melkebeek V; Cox E; Wuyts N; Haesebrouck F
Vaccine; 2013 Feb; 31(9):1305-11. PubMed ID: 23306368
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight.
Wilson S; Van Brussel L; Saunders G; Taylor L; Zimmermann L; Heinritzi K; Ritzmann M; Banholzer E; Eddicks M
Vaccine; 2012 Dec; 30(52):7625-9. PubMed ID: 23084853
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of intradermal vaccination against porcine enzootic pneumonia (Mycoplasma hyopneumoniae).
Tassis PD; Papatsiros VG; Nell T; Maes D; Alexopoulos C; Kyriakis SC; Tzika ED
Vet Rec; 2012 Mar; 170(10):261. PubMed ID: 22262700
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs.
Thacker EL; Thacker BJ; Kuhn M; Hawkins PA; Waters WR
Am J Vet Res; 2000 Nov; 61(11):1384-9. PubMed ID: 11108184
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.
Michiels A; Arsenakis I; Boyen F; Krejci R; Haesebrouck F; Maes D
BMC Vet Res; 2017 Aug; 13(1):274. PubMed ID: 28851359
[TBL] [Abstract][Full Text] [Related]
7. Immune responses of a chimaeric protein vaccine containing Mycoplasma hyopneumoniae antigens and LTB against experimental M. hyopneumoniae infection in pigs.
Marchioro SB; Sácristan Rdel P; Michiels A; Haesebrouck F; Conceição FR; Dellagostin OA; Maes D
Vaccine; 2014 Aug; 32(36):4689-94. PubMed ID: 24909331
[TBL] [Abstract][Full Text] [Related]
8. The Mycoplasma hyopneumoniae recombinant heat shock protein P42 induces an immune response in pigs under field conditions.
Jorge S; de Oliveira NR; Marchioro SB; Fisch A; Gomes CK; Hartleben CP; Conceição FR; Dellagostin OA
Comp Immunol Microbiol Infect Dis; 2014 Sep; 37(4):229-36. PubMed ID: 25082621
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of recombinant Mycoplasma hyopneumoniae P97/P102 paralogs formulated with selected adjuvants as vaccines against mycoplasmal pneumonia in pigs.
Woolley LK; Fell SA; Gonsalves JR; Raymond BB; Collins D; Kuit TA; Walker MJ; Djordjevic SP; Eamens GJ; Jenkins C
Vaccine; 2014 Jul; 32(34):4333-41. PubMed ID: 24930717
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
11. Systems Immunology Characterization of Novel Vaccine Formulations for
Matthijs AMF; Auray G; Jakob V; García-Nicolás O; Braun RO; Keller I; Bruggman R; Devriendt B; Boyen F; Guzman CA; Michiels A; Haesebrouck F; Collin N; Barnier-Quer C; Maes D; Summerfield A
Front Immunol; 2019; 10():1087. PubMed ID: 31178860
[TBL] [Abstract][Full Text] [Related]
12. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant.
Djordjevic SP; Eamens GJ; Romalis LF; Nicholls PJ; Taylor V; Chin J
Aust Vet J; 1997 Jul; 75(7):504-11. PubMed ID: 9258425
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of attenuated Mycoplasma hyopneumoniae 168 strain with bacterial DNA enhances the local and systemic immune response after intranasal vaccination in pigs.
Li Y; Li P; Wang X; Yu Q; Yang Q
Vaccine; 2012 Mar; 30(12):2153-8. PubMed ID: 22266290
[TBL] [Abstract][Full Text] [Related]
14. Immune B cell responsiveness to single-dose intradermal vaccination against Mycoplasma hyopneumoniae.
Martelli P; Saleri R; Andrani M; Cavalli V; De Angelis E; Ferrari L; Borghetti P
Res Vet Sci; 2021 Dec; 141():66-75. PubMed ID: 34688042
[TBL] [Abstract][Full Text] [Related]
15. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
[TBL] [Abstract][Full Text] [Related]
16. [Intradermal versus intramuscular vaccine application in suckling piglets - Comparison with regard to dermal reactions, performance and procedural aspects].
Göller M; Fels M; Gerdts WR; Kemper N
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2018 Oct; 46(5):317-322. PubMed ID: 30340241
[TBL] [Abstract][Full Text] [Related]
17. Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains.
Villarreal I; Vranckx K; Calus D; Pasmans F; Haesebrouck F; Maes D
BMC Vet Res; 2012 Jan; 8():2. PubMed ID: 22225838
[TBL] [Abstract][Full Text] [Related]
18. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
19. Application of a sIgA-ELISA method for differentiation of Mycoplasma hyopneumoniae infected from vaccinated pigs.
Bai Y; Gan Y; Hua LZ; Nathues H; Yang H; Wei YN; Wu M; Shao GQ; Feng ZX
Vet Microbiol; 2018 Sep; 223():86-92. PubMed ID: 30173757
[TBL] [Abstract][Full Text] [Related]
20. Oral vaccination of piglets against Mycoplasma hyopneumoniae using silica SBA-15 as an adjuvant effectively reduced consolidation lung lesions at slaughter.
Mechler-Dreibi ML; Almeida HMS; Sonalio K; Martines MAC; Petri FAM; Zambotti BB; Ferreira MM; Storino GY; Martins TS; Montassier HJ; Sant'Anna OA; Fantini MCA; de Oliveira LG
Sci Rep; 2021 Nov; 11(1):22377. PubMed ID: 34789792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
